Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunburst Technology (Beijing Sunburst Technology Co., Ltd.) is a leading medical device and life science tools company specializing in high-end molecular imaging systems. Founded by a team from Tsinghua University, the company is a pioneer in digital PET technology, offering a comprehensive portfolio of PET/CT, PET/MRI, and SPECT systems for clinical diagnostics and preclinical research. Sunburst Technology also develops microfluidic-based radiopharmaceutical synthesis systems, enhancing the efficiency of molecular imaging workflows. The company's products are widely used in oncology, cardiology, and neurology for early disease detection and drug development research. With a strong focus on independent innovation and academic collaboration, Sunburst Technology has established itself as a leader in the Chinese molecular imaging market and is expanding its global presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunburst Technology.